Inarigivir soproxil

DB15063InvestigationalSmall molecule

Inarigivir soproxil is under investigation in clinical trial NCT03434353 (Study to Evaluate the Antiviral Activity of Inarigivir (GS-9992) Plus Tenofovir Alafenamide (TAF) for 12 Weeks in Adults With Chronic Hepatitis...

Formula / weight: C₂₅H₃₄N₇O₁₃PS · 703.62 g/mol (avg)
Code names: SB 9200

Resolves to

Compound

UNII365052M0DKCAS942123-43-5ChEMBLCHEMBL1076930

Structure

InChIKeyCJCYTUJOSMYXLE-JDLSZIHUSA-NSMILESCO[C@@H]1[C@H](OP(=O)(OC[C@H]2O[C@H](C[C@@H]2O)N2C=NC3=C2N=CN=C3N)SCOC(=O)OC(C)C)[C@@H](CO)O[C@H]1N1C=CC(=O)NC1=O

Targets

Q9HC29NOD2

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Inarigivir soproxil, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account